Table 2.

Number of patients and crude ratios (R) of the prescribed ESA dose (HD to PD patients) across 12 increments of achieved hemoglobin levels in 10,380 PD patients and 121,863 HD patients between 7/2001 and 6/2006

Hemoglobin	ALL (n = 132,243)
	PD, n (%)	HD, n (%)	crude ratios (R)
<9.0 g/dl	95 (1)	1,687 (1)	3.9
9.0 to <9.5 g/dl	108 (1)	1,541 (1)	3.7
9.5 to <10.0 g/dl	179 (2)	2,621 (2)	3.1
10.0 to <10.5 g/dl	324 (3)	4,189 (3)	3.3
10.5 to <11.0 g/dl	698 (7)	6,859 (6)	3.4
11.0 to <11.5 g/dl	1,369 (13)	12,907 (11)	3.1
11.5 to <12.0 g/dl	2,291 (22)	27,689 (23)	2.9
12.0 to <12.5 g/dl	2,313 (22)	35,144 (29)	3.1
12.5 to <13.0 g/dl	1,521 (15)	18,554 (15)	3.0
13.0 to <13.5 g/dl	767 (7)	6,759 (6)	3.0
13.5 to <14.0 g/dl	381 (4)	2,322 (2)	2.9
≥ 14 g/dl	334 (3)	1,591 (1)	2.9
All patients	10,380	121,863	3.1